Does ERLOTINIB Cause Myelosuppression? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Myelosuppression have been filed in association with ERLOTINIB (Erlotinib). This represents 0.1% of all adverse event reports for ERLOTINIB.
19
Reports of Myelosuppression with ERLOTINIB
0.1%
of all ERLOTINIB reports
3
Deaths
2
Hospitalizations
How Dangerous Is Myelosuppression From ERLOTINIB?
Of the 19 reports, 3 (15.8%) resulted in death, 2 (10.5%) required hospitalization, and 1 (5.3%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERLOTINIB. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does ERLOTINIB Cause?
Death (5,000)
Rash (4,648)
Diarrhoea (3,448)
Fatigue (1,548)
Nausea (1,366)
Drug ineffective (1,207)
Off label use (1,190)
Decreased appetite (998)
Malignant neoplasm progression (954)
Dry skin (953)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which ERLOTINIB Alternatives Have Lower Myelosuppression Risk?
ERLOTINIB vs ERTAPENEM
ERLOTINIB vs ERTUGLIFLOZIN PIDOLATE
ERLOTINIB vs ERYTHROMYCIN
ERLOTINIB vs ERYTHROMYCIN ETHYLSUCCINATE
ERLOTINIB vs ERYTHROMYCIN LACTOBIONATE